President Donald Trump’s freeze on U.S. foreign aid has temporarily suspended key anti-narcotics programs in Mexico, impacting efforts to curb the flow of fentanyl into the U.S. The freeze affects all programs under the State Department’s Bureau of International Narcotics and Law Enforcement (INL), which trains Mexican authorities to dismantle clandestine fentanyl labs and intercept precursor chemicals.
INL initiatives, including drug-detecting canines that helped seize millions of fentanyl pills in 2023, have been put on hold. Former State Department official Dafna H. Rand criticized the freeze, stating it weakens the U.S.'s ability to combat the fentanyl crisis, which has claimed over 450,000 American lives in the past decade.
The freeze follows Trump’s "America First" policy, halting billions in foreign assistance worldwide. Despite Secretary of State Marco Rubio issuing waivers for humanitarian aid, most programs remain in limbo. Some officials suggest exemptions for foreign anti-narcotics programs are being considered, though no decision has been made on INL’s Mexico projects.
Trump has pledged to destroy Mexican cartels and threatened 25% tariffs on Mexico if it fails to curb fentanyl trafficking and illegal immigration. He has also pushed for designating cartels as terrorist organizations, expanding U.S. authority to target them. U.S. military surveillance of Mexican cartels has increased, raising concerns that Trump’s approach is shifting from cooperation with Mexico to unilateral action.
During his campaign, Trump called for military operations against cartels, signaling a tougher stance. While the administration’s next steps remain uncertain, the suspension of INL programs has stalled critical efforts to combat fentanyl at its source, complicating U.S.-Mexico cooperation on drug enforcement.


Keir Starmer Urges Prince Andrew to Testify in U.S. Epstein Investigation
Venezuela Proposes Amnesty Law and Plans to Transform Helicoide Prison
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Meta Faces Lawsuit Over Alleged Approval of AI Chatbots Allowing Sexual Interactions With Minors
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Trump Says Fed Pick Kevin Warsh Could Win Democratic Support in Senate Confirmation
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
DOJ Urges Judge to Block Lawmakers’ Bid for Special Master in Jeffrey Epstein Records Case
Jerome Powell Attends Supreme Court Hearing on Trump Effort to Fire Fed Governor, Calling It Historic
Medvedev Warns World Is Growing More Dangerous but Says Russia Seeks to Avoid Global Conflict
Russian Drone Strike Kills Miners as Ukraine Pushes for Peace Talks Amid Energy Crisis
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Former South Korean President Yoon Suk Yeol Faces Historic Court Ruling Over Failed Martial Law Attempt
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive 



